Prometheus is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic
products that enable physicians to provide greater individualized patient care.
Prometheus Laboratories Inc. Announces Inclusion of Proleukin® in SITC Guidelines
Prometheus Launches PROCLIVITY 02 Clinical Trial of Proleukin®
Prometheus Presents New Data on Growing IBD Diagnostic Portfolio at DDW 2013
Prometheus Launches PROCLIVITY 01 Clinical Trial of Proleukin®
Prometheus Launches New Adalimumab Drug and Antibody Levels Monitoring Test